Abstract
BACKGROUND: Cisplatin is considered safe to use during the second and third trimesters of pregnancy in patients with cancer.
CASE: A 34-year-old pregnant woman was diagnosed with cervical cancer. She received five weekly dosages of cisplatin and paclitaxel, starting at 26 5/7 weeks of gestation. An elective cesarean delivery was performed at 34 4/7 weeks of gestation. After birth, the neonate was diagnosed with severe bilateral perceptive hearing loss.
CONCLUSION: Cisplatin during the second and third trimesters of pregnancy may lead to fetal ototoxicity.
Original language | English |
---|---|
Pages (from-to) | 454-6 |
Number of pages | 3 |
Journal | Obstetrics and Gynecology |
Volume | 124 |
Issue number | 2 Pt 2 Suppl 1 |
DOIs | |
Publication status | Published - Aug 2014 |
Externally published | Yes |